Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 11, 2013

Acasti, Alnylam, Galena, GW, Portola, Revalasio, Zalicus

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I Galena tests ovarian cancer vaccine . . . read more GW begins GBM trial . . . read more Phase II Portola compound reverses Xarelto . . . read more Revalasio begins MS trial . . . read more Zalicus’ Z160 fails in LSR, PHN studies . . . read more Filings Acasti files IND for CaPre . . . read more Alnylam gets fast track for patisiran . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters